UAE at a glance
- Population
- 11.5 million 2025
- Life expectancy at birth
- 83.1 years, 2024
- People aged 65 and over
- 1.8 % of people, 2025
- Health spending per person
- 2,402 US$ per person, 2023
- Doctors
- 2.99 per 1,000 people, 2023
UAE Myopia Control Market Industry Trends and Forecast to 2034: Segmented by (Product, Age, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$50.6 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $15.2 Mn | — | — |
| 2025 (base) | $17.7 Mn | +$2.5 Mn | — |
| 2026 (forecast) | $20.6 Mn | +$2.9 Mn | +16.2% |
| 2027 (forecast) | $23.9 Mn | +$3.3 Mn | +35% |
| 2028 (forecast) | $27.8 Mn | +$3.9 Mn | +56.9% |
| 2029 (forecast) | $32.2 Mn | +$4.5 Mn | +82.3% |
| 2030 (forecast) | $37.5 Mn | +$5.2 Mn | +111.9% |
| 2031 (forecast) | $43.5 Mn | +$6.1 Mn | +146.2% |
| 2032 (forecast) | $50.6 Mn | +$7.1 Mn | +186.1% |
| 2033 (forecast) | $58.8 Mn | +$8.2 Mn | +232.4% |
| 2034 (forecast) | $68.3 Mn | +$9.5 Mn | +286.2% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Myopia control slows short-sightedness getting worse in children, using special glasses, contact lenses and eye drops.
Key segments of the myopia Control market include product (Myopia Control Spectacle Lenses, Orthokeratology Lenses and Soft Multifocal Contact Lenses) and age (Children and Teenagers).
An ageing population, more people with diabetes and long-term conditions, better treatments and wider access to specialist care are driving the myopia Control market.
Longer-acting treatments, home-based care and screening in emerging markets give the myopia Control market room to grow.
High costs of new treatments, specialist shortages, low awareness and limited reimbursement in some countries hold back the myopia Control market.
The myopia Control market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how myopia Control products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in UAE.
What doctors and scientists are doing in Myopia Control right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
UAE · 1 shared keyword
UAE
UAE
UAE
UAE
UAE
Digital Health · UAE
Healthcare Services · UAE
Public Health · UAE
Pharmaceuticals · UAE
Pharmaceuticals · UAE
Public Health · UAE